 | |||||
| disease | |||||
| 网页 | |||||
| Clinical trial: CRISPR therapy for sickle cell disease - Innovative Genomics Institute (IGI) The FDA approved the first test of a CRISPR therapy for sickle cell disease that directly corrects the underlying genetic defect.
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
 以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment